6 results
ARS
2024 FY
CCCC
C4 Therapeutics Inc
30 Apr 24
Annual report to shareholders
8:52am
management process is overseen by our Chief Legal Officer and Chief Financial Officer. In collecting information on enterprise risk, cyber security
PRE 14A
CCCC
C4 Therapeutics Inc
18 Apr 23
Preliminary proxy
7:59am
, operational, cyber security and data privacy, competitive, legal, regulatory, hedging and accounting risks, and discussing the guidelines and policies
- Prev
- 1
- Next